Datamatics, today announced that it has been appraised at Level 5, the highest maturity level of the CMMI for Software Development and Business Process Management Services.
Datamatics, has entered into a strategic partnership with Alkermes, a global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.
The Board of Directors of Datamatics Global Services Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.
The Board of Directors of Datamatics Global Services Ltd has recommended, final dividend of Rs. 3.75 and special dividend of Rs. 1.25 per equity share of the face value of Rs. 5 each for the financial year ended March 31, 2023.
Datamatics Global Services Ltd., in association with the Market Research Society of India (MRSI), announced the 11th Dr. Lalit Kanodia Laureate Award for Technology Excellence in Market Research 2022.